High Tower Advisors, LLC Charles River Laboratories International, Inc. Transaction History

High Tower Advisors, LLC

  • $64.2 Billion
  • Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 11,030 shares of CRL stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,030
Previous 12,047 8.44%
Holding current value
$2.36 Million
Previous $3.26 Million 30.21%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$206.39 - $268.73 $209,898 - $273,298
-1,017 Reduced 8.44%
11,030 $2.28 Million
Q1 2024

May 06, 2024
BUY
$203.52 - $273.43 $166,886 - $224,212
820 Added 7.3%
12,047 $3.26 Million
Q4 2023

Feb 12, 2024
SELL
$164.52 - $238.84 $452,759 - $657,287
-2,752 Reduced 19.69%
11,227 $2.65 Million
Q3 2023

Nov 08, 2023
SELL
$194.44 - $217.61 $66,109 - $73,987
-340 Reduced 2.37%
13,979 $2.74 Million
Q2 2023

Aug 14, 2023
SELL
$183.71 - $210.25 $766,621 - $877,373
-4,173 Reduced 22.57%
14,319 $3.01 Million
Q1 2023

May 11, 2023
SELL
$191.89 - $259.92 $2.91 Million - $3.94 Million
-15,151 Reduced 45.03%
18,492 $3.73 Million
Q4 2022

Feb 08, 2023
BUY
$197.11 - $250.07 $1.13 Million - $1.43 Million
5,709 Added 20.44%
33,643 $7.33 Million
Q3 2022

Nov 09, 2022
BUY
$182.44 - $250.54 $1.27 Million - $1.74 Million
6,949 Added 33.11%
27,934 $5.53 Million
Q2 2022

Aug 10, 2022
SELL
$204.13 - $302.4 $1.91 Million - $2.84 Million
-9,375 Reduced 30.88%
20,985 $4.48 Million
Q1 2022

May 12, 2022
SELL
$255.51 - $362.11 $127,243 - $180,330
-498 Reduced 1.61%
30,360 $8.64 Million
Q4 2021

Feb 10, 2022
BUY
$351.38 - $448.68 $4.14 Million - $5.28 Million
11,773 Added 61.69%
30,858 $11.7 Million
Q3 2021

Nov 12, 2021
BUY
$372.64 - $458.3 $41,735 - $51,329
112 Added 0.59%
19,085 $7.86 Million
Q2 2021

Aug 06, 2021
BUY
$294.17 - $371.65 $205,919 - $260,154
700 Added 3.83%
18,973 $7.02 Million
Q1 2021

May 10, 2021
BUY
$249.67 - $299.48 $408,959 - $490,548
1,638 Added 9.85%
18,273 $5.29 Million
Q4 2020

Feb 10, 2021
BUY
$222.0 - $252.62 $19,092 - $21,725
86 Added 0.52%
16,635 $4.13 Million
Q3 2020

Nov 13, 2020
BUY
$175.56 - $226.45 $78,299 - $100,996
446 Added 2.77%
16,549 $3.75 Million
Q2 2020

Aug 10, 2020
BUY
$118.84 - $189.72 $155,323 - $247,964
1,307 Added 8.83%
16,103 $2.81 Million
Q1 2020

May 21, 2020
BUY
$98.9 - $178.34 $11,274 - $20,330
114 Added 0.78%
14,796 $1.88 Million
Q4 2019

Feb 14, 2020
BUY
$126.05 - $152.76 $44,999 - $54,535
357 Added 2.49%
14,682 $2.25 Million
Q3 2019

Nov 12, 2019
BUY
$125.07 - $143.67 $41,398 - $47,554
331 Added 2.37%
14,325 $1.9 Million
Q2 2019

Aug 13, 2019
BUY
$123.4 - $148.55 $52,198 - $62,836
423 Added 3.12%
13,994 $1.99 Million
Q1 2019

May 15, 2019
BUY
$104.82 - $146.73 $69,705 - $97,575
665 Added 5.15%
13,571 $1.97 Million
Q4 2018

Feb 14, 2019
BUY
$105.09 - $137.23 $706,730 - $922,871
6,725 Added 108.8%
12,906 $1.46 Million
Q3 2018

Nov 09, 2018
BUY
$112.11 - $134.54 $98,768 - $118,529
881 Added 16.62%
6,181 $831,000
Q2 2018

Aug 14, 2018
SELL
$102.37 - $117.25 $416,850 - $477,442
-4,072 Reduced 43.45%
5,300 $590,000
Q1 2018

May 15, 2018
BUY
$98.19 - $115.2 $492,913 - $578,304
5,020 Added 115.35%
9,372 $987,000
Q4 2017

Feb 14, 2018
SELL
$100.43 - $118.09 $109,267 - $128,481
-1,088 Reduced 20.0%
4,352 $478,000
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $526,156 - $594,374
5,440
5,440 $586,000

Others Institutions Holding CRL

# of Institutions
712
Shares Held
51.6M
Call Options Held
233K
Put Options Held
236K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.9B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email